Adma Biologics | ADMA - Ebitda





Ebitda 変化する 日付
Adma Biologics USD 61.07M 12.52M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Novavax USD 19.36M 190.79M 2025-12
Omeros USD -47.96M 7.39M 2023-09
Takeda JPY 364.46B 214.21B 2026-06